Yifan Xinfu Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2024: 0.53%

Yifan Xinfu Pharmaceutical Co Ltd (002019) has an Asset Resilience Ratio of 0.53% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Yifan Xinfu Pharmaceutical Co Ltd (002019) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥65.00 Million
≈ $9.51 Million USD Cash + Short-term Investments

Total Assets

CN¥12.37 Billion
≈ $1.81 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2023)

This chart shows how Yifan Xinfu Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Yifan Xinfu Pharmaceutical Co Ltd (002019) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Yifan Xinfu Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Yifan Xinfu Pharmaceutical Co Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥65.00 Million 0.53%
Total Liquid Assets CN¥65.00 Million 0.53%

Asset Resilience Insights

  • Limited Liquidity: Yifan Xinfu Pharmaceutical Co Ltd maintains only 0.53% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Yifan Xinfu Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Yifan Xinfu Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
AbbVie Inc
NYSE:ABBV
Drug Manufacturers - General 0.02%
Roche Holding AG
SW:ROG
Drug Manufacturers - General 15.37%
Biogen Inc
NASDAQ:BIIB
Drug Manufacturers - General 2.74%
CSPC Pharmaceutical Group Limited
F:CVG
Drug Manufacturers - General 4.64%
AstraZeneca PLC
LSE:AZN
Drug Manufacturers - General 0.03%
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
Drug Manufacturers - General 5.37%
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3
Drug Manufacturers - General 10.10%
Firebrick Pharma Ltd
AU:FRE
Drug Manufacturers - General 0.29%

Annual Asset Resilience Ratio for Yifan Xinfu Pharmaceutical Co Ltd (2015–2023)

The table below shows the annual Asset Resilience Ratio data for Yifan Xinfu Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 0.65% CN¥75.01 Million
≈ $10.98 Million
CN¥11.50 Billion
≈ $1.68 Billion
-0.11pp
2022-12-31 0.76% CN¥95.50 Million
≈ $13.97 Million
CN¥12.54 Billion
≈ $1.84 Billion
-2.86pp
2021-12-31 3.62% CN¥440.39 Million
≈ $64.44 Million
CN¥12.17 Billion
≈ $1.78 Billion
+3.22pp
2020-12-31 0.40% CN¥46.73 Million
≈ $6.84 Million
CN¥11.71 Billion
≈ $1.71 Billion
+0.05pp
2019-12-31 0.35% CN¥39.00 Million
≈ $5.71 Million
CN¥11.07 Billion
≈ $1.62 Billion
-1.03pp
2018-12-31 1.39% CN¥135.58 Million
≈ $19.84 Million
CN¥9.77 Billion
≈ $1.43 Billion
-6.37pp
2017-12-31 7.76% CN¥680.00 Million
≈ $99.51 Million
CN¥8.77 Billion
≈ $1.28 Billion
+4.93pp
2016-12-31 2.83% CN¥197.50 Million
≈ $28.90 Million
CN¥6.98 Billion
≈ $1.02 Billion
+1.79pp
2015-12-31 1.03% CN¥47.00 Million
≈ $6.88 Million
CN¥4.55 Billion
≈ $665.33 Million
--
pp = percentage points

About Yifan Xinfu Pharmaceutical Co Ltd

SHE:002019 China Drug Manufacturers - General
Market Cap
$1.99 Billion
CN¥13.60 Billion CNY
Market Cap Rank
#6284 Global
#1390 in China
Share Price
CN¥11.18
Change (1 day)
-0.53%
52-Week Range
CN¥11.18 - CN¥16.29
All Time High
CN¥32.51
About

Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products, raw materials, and polymer materials in Southeast Asia, Europe and North America, Singapore, South Korea, Italy, China, Germany, and the United States. It offers Chinese patent medicines, chemical medicines and biological medicines; and vitamin products, including vitamin B5 an… Read more